Mark E. Saad - Mar 2, 2023 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Herriot Tabuteau, M.D., Attorney in Fact
Stock symbol
AXSM
Transactions as of
Mar 2, 2023
Transactions value $
$0
Form type
4
Date filed
3/6/2023, 05:12 PM
Previous filing
Jun 7, 2022
Next filing
Jun 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Award $0 +2.22K $0.00 2.22K Mar 2, 2023 Common Stock 2.22K $65.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 2,224 options elected to be received in lieu of cash compensation earned in 2022. All of such options are immediately exercisable.